| # | Drug | Count |
|---|---|---|
| 0 | PREDNISONE | 148 |
| 1 | METHOTREXATE SODIUM | 86 |
| 2 | RITUXIMAB | 84 |
| 3 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 83 |
| 4 | MYCOPHENOLATE MOFETIL | 82 |
| 5 | METHOTREXATE | 77 |
| 6 | ALBUTEROL SULFATE | 74 |
| 7 | ASPIRIN | 67 |
| 8 | DEXAMETHASONE | 66 |
| 9 | DEXAMETHASONE 1.5 MG | 65 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | THIOGUANINE | 18 | 0.0085 |
| 1 | GUAIFENESIN AND CODEINE PHOSPHATE | 1 | 0.0075 |
| 2 | SORBITOL | 3 | 0.0050 |
| 3 | ARFORMOTEROL TARTRATE | 1 | 0.0042 |
| 4 | NELARABINE | 4 | 0.0041 |
| 5 | POLYETHYLENE GLYCOL 3350, SODIUM CHLORIDE, SODIUM BICARBONATE, POTASSIUM CHLORIDE | 1 | 0.0040 |
| 6 | ESMOLOL HYDROCHLORIDE | 1 | 0.0037 |
| 7 | ADALIMUMAB-ATTO | 6 | 0.0037 |
| 8 | AMOXICILLIN AND CLAVULANATE POTASSIUM | 15 | 0.0033 |
| 9 | SUTIMLIMAB-JOME | 1 | 0.0031 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 317 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 130 |
| 2 | CD20-directed Cytolytic Antibody [EPC] | 110 |
| 3 | Folate Analog Metabolic Inhibitor [EPC] | 77 |
| 4 | Proton Pump Inhibitor [EPC] | 75 |
| 5 | Alkylating Drug [EPC] | 69 |
| 6 | Platelet Aggregation Inhibitor [EPC] | 67 |
| 7 | Tumor Necrosis Factor Blocker [EPC] | 66 |
| 8 | Provitamin D2 Compound [EPC] | 58 |
| 9 | Purine Antimetabolite [EPC] | 54 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 46 | 0.0669 |
| 1 | CD38-directed Cytolytic Antibody [EPC] | 23 | 0.0039 |
| 2 | Classical Complement Pathway Inhibitor [EPC] | 1 | 0.0031 |
| 3 | Antileishmanial [EPC] | 1 | 0.0026 |
| 4 | Provitamin D2 Compound [EPC] | 58 | 0.0019 |
| 5 | Diagnostic Dye [EPC] | 1 | 0.0015 |
| 6 | Human Immunoglobulin G [EPC] | 29 | 0.0014 |
| 7 | Echinocandin Antifungal [EPC] | 10 | 0.0012 |
| 8 | alpha-1 Adrenergic Agonist [EPC] | 5 | 0.0011 |
| 9 | Lipid-based Polyene Antifungal [EPC] | 11 | 0.0009 |